Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : BMS-986036
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Undisclosed
Sponsor : Bristol Myers Squibb
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
August 02, 2018
Lead Product(s) : BMS-986036
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Undisclosed
Sponsor : Bristol Myers Squibb
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Emricasan
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Undisclosed
Sponsor : Conatus Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 12, 2018
Lead Product(s) : Emricasan
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Undisclosed
Sponsor : Conatus Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Emricasan
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Undisclosed
Sponsor : Conatus Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 20, 2018
Lead Product(s) : Emricasan
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Undisclosed
Sponsor : Conatus Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Breathid Hp Lab System
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 19, 2016
Lead Product(s) : Breathid Hp Lab System
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : 13-C Sodium Octanoate
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase II
Sponsor : Toronto General Hospital | Medical University of South Carolina | Northwestern University | Henry Ford Health System | Hadassah Medical Organization
Deal Size : Inapplicable
Deal Type : Inapplicable
Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI
Details : Undisclosed
Product Name : Undisclosed
Product Type : Radiolabeled Compounds
Upfront Cash : Inapplicable
September 13, 2011
Lead Product(s) : 13-C Sodium Octanoate
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase II
Sponsor : Toronto General Hospital | Medical University of South Carolina | Northwestern University | Henry Ford Health System | Hadassah Medical Organization
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benzoyl-L-Tyrosyl-Alanine
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase II
Sponsor : Virginia Commonwealth University | Asian Institute of Gastroenterology, Hyderabad, India
Deal Size : Inapplicable
Deal Type : Inapplicable
BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 14, 2010
Lead Product(s) : Benzoyl-L-Tyrosyl-Alanine
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase II
Sponsor : Virginia Commonwealth University | Asian Institute of Gastroenterology, Hyderabad, India
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Caprylic Acid
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Recipient : Virginia Commonwealth University
Deal Size : Inapplicable
Deal Type : Inapplicable
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 19, 2010
Lead Product(s) : Caprylic Acid
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Recipient : Virginia Commonwealth University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Grapefruit Juice
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase II/ Phase III
Recipient : Hadassah Medical Organization
Deal Size : Inapplicable
Deal Type : Inapplicable
¹³C-Methacetin Breath Test (MBT) Methodology Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
September 20, 2010
Lead Product(s) : Grapefruit Juice
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase II/ Phase III
Recipient : Hadassah Medical Organization
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
